Teleflex Incorporated (TFX) SEC Filings & Earnings Calls

Integration risk: Biotronik Vascular Intervention business integration taking longer than expected, causing revenue guidance reduction.

“Integration of the acquired Biotronik Vascular Intervention business is progressing, though taking longer than expected, and we updated our revenue outlook accordingly.” · word for word

Tariff exposure

“Gross margin for the three months ended June 30, 2026 decreased 190 basis points, or 3.2%, compared to the prior year period, primarily due to the adverse impact from tariffs enacted in 2025” · word for word

Activist stockholder distraction

“On March 27, 2026, Irenic Capital Management L.P. (“Irenic”) issued a press release advocating changes to the composition of our board of directors as well as the engagement of independent advisors in order to facilitate an evaluation of strategic alternatives for our company.” · word for word

Integration risk from VI Business

“EMEA operating profit for the three and six months ended June 30, 2026 decreased $9.3 million, or 52.5%, and $10.4 million, or 33.5%, respectively, compared to the prior year periods, which was primarily attributable to increases in operating costs associated with the acquired VI Business”

Divestiture execution risk

“the Acute Care and IU businesses sale is currently anticipated to be completed in the fourth quarter of 2026, subject to customary closing conditions, including receipt of regulatory approvals and other closing conditions.” · word for word

Divestiture may result in unanticipated difficulties and expenditures in connection with integration programs.

“unanticipated difficulties and expenditures in connection with integration programs” · word for word

Customer and shareholder reaction to the strategic divestiture could impact business relationships.

“customer and shareholder reaction to the strategic divestiture” · word for word

Forward-looking statements caution about risks; no specific risk identified.

“Standard forward-looking statement disclaimer.”

Covenants require max total net leverage ratio of 4.50x and min interest coverage of 3.00x; failure could trigger default.

“Company is required to maintain a maximum total net leverage ratio of 4.50 to 1.00 and a minimum interest coverage ratio of 3.00 to 1.00.”

Non-GAAP measures exclude restructuring, impairment, acquisition costs, and other items; may obscure underlying trends.

“Adjusted diluted EPS excludes restructuring, impairment, acquisition, divestiture, and other items.”

Activist stockholder campaign

“On March 27, 2026, Irenic Capital Management L.P. (“Irenic”) issued a press release advocating changes to the composition of our board of directors as well as the engagement of independent advisors in order to facilitate an evaluation of strategic alternatives for our company.” · word for word

Tariff uncertainty

“Gross margin for the three months ended March 31, 2026 decreased 560 basis points, or 9.1%, compared to the prior year period, primarily due to the adverse impact from tariffs enacted in 2025.” · word for word

CEO transition

“On January 8, 2026, we announced the departure of our former Chairman, President and Chief Executive Officer, Liam J. Kelly, and the appointment of Stuart A. Randle as Interim President and Chief Executive Officer.” · word for word

CEO transition risk; integration and strategic execution uncertainty.

“Appointment of new CEO effective June 8, 2026; interim CEO continues as board member.”

CEO Transition Risk

“On January 8, 2026, we announced the departure of Liam J. Kelly from his roles as the Company’s President and Chief Executive Officer... The Board has engaged Spencer Stuart... to assist with the search for a permanent President and Chief Executive Officer.” · word for word

Divestiture Execution Risk

“The sale transactions, which are on track to close in the second half of 2026, are expected to deliver net proceeds of approximately $1.8 billion after tax.” · word for word

Revenue and EPS Miss in 2025

“Corporate Revenue: 0% payout; EPS: 0% payout. Total payout for CEO: 25.9% of target.”

Activist pressure may force accelerated strategic actions; execution risk on divestitures and restructuring.

“Irenic demanded immediate strategic alternatives process; Teleflex rebuts mischaracterizations.”

FTC Second Request for Acute Care/Urology divestiture introduces regulatory uncertainty and potential delay.

“Acute Care and Urology Purchaser received a Second Request from the FTC, extending HSR waiting period.”

Tariff cost pressure on gross margin

“recently enacted U.S. tariffs and accompanying retaliatory measures adversely impacted results, primarily due to higher import costs associated with our operations in the European Union, as well as to products manufactured in Mexico that are not currently compliant with the United States-Mexico-Canada Agreement (USMCA).” · word for word

GLP-1 disruption to bariatric surgery demand

“The indicators of a potential impairment primarily arose from lower than expected sales of our Titan SGS product line and anticipated continuing reduced demand for bariatric surgery procedures in future periods, driven by the growing adoption of GLP-1 products.” · word for word

China VBP pricing pressure

“Asia net revenues ... partially offset by price decreases primarily due to the implementation of volume-based procurement programs in China.”

Strategic divestiture execution risk

“We can make no assurance that the announced transactions will be consummated on the timeframe contemplated or at all.” · word for word

Sterilization disruption risk

“Failure of our contract sterilizers to achieve compliance with the final rule by the applicable deadline would significantly impair our ability to provide sufficient quantities of sterilized products to our customers.” · word for word

Restructuring execution risk; stranded costs of $90M in 2026 pressure earnings; divestiture closing in H2 2026 adds uncertainty.

“Restructuring plan with $31M-$37M charges; stranded costs $90M; divestitures expected to close in H2 2026.”

Leadership transition risk: CEO departure without named successor may disrupt strategy and operations.

“CEO departed effective Jan 7, 2026; no successor announced; transition period ends Mar 31, 2026.”

CEO departure and revenue guidance cut signal operational challenges.

“CEO departure; revenue guidance reduced; softer demand and order delays.”

Execution risk on closing transactions and regulatory approvals

“Transactions expected to close in H2 2026, subject to regulatory approvals”

GLP-1 substitution risk for bariatric devices

“lower than expected sales of our Titan SGS product line and anticipated continuing reduced demand for bariatric surgery procedures in future periods, driven by the growing adoption of GLP-1 products” · word for word

Tariff cost pressure

“The recently enacted U.S. tariffs and accompanying retaliatory measures, had a negative impact on our gross margins and cash flows for the three and nine months ended September 28, 2025.” · word for word

China channel inventory risk

“We are currently monitoring increased inventory levels of our intra-aortic balloon pumps and catheters at some of our distributors in China, as we have observed that their sales to third parties have been slower than had been anticipated” · word for word

Integration risk from VI Business acquisition

“The acquisition adds a broad suite of coronary and peripheral medical devices... we may not realize planned synergies” · word for word

Separation execution risk

“There can be no guarantees that the proposed separation will be completed on the terms and within the timeframe we announced, or at all.” · word for word

Goodwill and asset impairment of $512M indicates potential overpayment for acquisitions or deteriorating business outlook.

“Goodwill and asset impairment charges for the nine months ended September 28, 2025 totaled $512.0 million” · word for word

Lowered adjusted constant currency revenue growth guidance to 6.9%-7.4% from prior.

“Lowering adjusted constant currency revenue growth guidance range to 6.90% to 7.40%” · word for word

IABP order rates lower than expected.

“lower than expected order rates in our intra-aortic balloon pump portfolio” · word for word